Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aurora Cannabis Inc T.ACB

Alternate Symbol(s):  ACB | T.ACB.WS.U

Aurora Cannabis Inc. is a Canada-based medical cannabis company. The Company's principal business lines are focused on the production, distribution, and sale of cannabis related products in Canada and internationally. The Company’s segments include Canadian Cannabis, European Cannabis and Plant Propagation. The Company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being and Greybeard, as well as CBD brands, Reliva and KG7. Its medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co, as well as international brands, Pedanios, Bidiol and CraftPlant. Its cannabis products are primarily cultivated and manufactured in the facilities in Edmonton, Alberta; Bradford Ontario; Pemberton, British Columbia, and Odense, Denmark. The Company is focused on offering its cannabis products to global medical cannabis market, recreational cannabis market and global hemp-derived cannabidiol (CBD) markets.


TSX:ACB - Post by User

Bullboard Posts
Comment by Analystguyon Nov 08, 2018 7:13pm
210 Views
Post# 28947415

RE:RE:1st quarter 2019 Investor Confrence

RE:RE:1st quarter 2019 Investor Confrence Is Monday not a Canadian banking holiday (Remembrance Day)? If so, it is doubtful any Canadian analysts will be on the call,

Also issuing news after the close of markets on a Friday is ususally reserved for bad news (see TGODs announcement re ACB option lapse). Playing to a limited analyst audience on Monday raises further concern on the quarter.

If you remember, Cam Battley stated on a Midas Letter interview back in the summer that while September Q42018 earnings would be good, MedReleaf earnigs would not be incorporated until this November's report. All eyes will be on this report.

I am hopefull that ACB can demonstrate strong earnings, but the timing of the call and earnings report doesn't bode well for me.
Bullboard Posts